2023Q1营收归零,继续亏损,目前看不到投资价值。查看全文
美股律师郝俊波2021-06-09 17:18
$AcelRx制药(ACRX)$ 【AcelRx Pharmaceuticals Inc(ACRX)证券诉讼信息 】
AcelRx Pharmaceuticals Inc(ACRX)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2020年3月17日至2021年2月12日期间就公司的业务、运营及合规问题进行虚假陈述,未向投资者披露以下重大不...查看全文
$AcelRx制药(ACRX)$ 美东时间 2019-05-08 盘后 披露财报,预期EPS -0.23 网页链接
$AcelRx制药(ACRX)$ 8-K - Current report Filed: 2019-03-07 AccNo: 0001437749-19-004327 Size: 171 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx制药(ACRX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-07 AccNo: 0001437749-19-004353 Size: 9 MB 网页链接
$AcelRx制药(ACRX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-07 AccNo: 0001437749-19-004354 Size: 79 KB 网页链接
$AcelRx制药(ACRX)$ 美东时间 2019-03-07 盘后 披露财报,预期EPS -0.23 网页链接
$AcelRx制药(ACRX)$ 美东时间 2019-03-07 盘后 披露财报,预期EPS -0.2 网页链接
$AcelRx制药(ACRX)$ 8-K - Current report Filed: 2019-02-14 AccNo: 0001437749-19-002640 Size: 42 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$AcelRx制药(ACRX)$ 8-K - Current report Filed: 2019-01-11 AccNo: 0001437749-19-000739 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$AcelRx Pharmaceuticals, Inc.(ACRX)$ 内部交易: 2018-12-12,CEO,Angotti Vincent J. ,买入,10000普通股, $2.99
$AcelRx Pharmaceuticals, Inc.(ACRX)$ 内部交易: 2018-11-19,Chief Medical Officer,Palmer Pamela P ,买入,16000普通股, $3.07